Interim CFO of Inspire Medical (INSP) disposes shares for tax withholding

Rhea-AI Filing Summary

Inspire Medical Systems interim CFO Richard Buchholz disposed of 579 shares of common stock at $59.76 per share to cover taxes due on the vesting of a restricted stock unit award. After this tax-withholding disposition, he directly holds 43,988 shares and indirectly holds 1,475 shares through his son.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buchholz Richard

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		579(1)	D	$59.76	43,988	D
Common Stock								1,475	I	By Son
Common Stock								1,475	I	By Son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

	/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Inspire Medical Systems (INSP) report for Richard Buchholz?

Inspire Medical Systems reported that interim CFO Richard Buchholz had 579 shares of common stock withheld to cover taxes on a restricted stock unit vesting. This tax-withholding disposition used existing shares rather than an open-market sale.

How many Inspire Medical Systems (INSP) shares were disposed of for tax withholding?

A total of 579 Inspire Medical Systems common shares were disposed of to satisfy tax obligations tied to a restricted stock unit vesting. The shares were valued at $59.76 each, according to the reported transaction details.

How many Inspire Medical Systems (INSP) shares does Richard Buchholz hold after the transaction?

After the tax-withholding disposition, interim CFO Richard Buchholz directly owns 43,988 Inspire Medical Systems common shares. He also has indirect ownership of 1,475 additional shares held by his son, as reflected in the filing’s ownership table.

Was the Inspire Medical Systems (INSP) insider transaction an open-market sale?

No, the transaction was not an open-market sale. The 579 shares were withheld by Inspire Medical Systems to cover taxes due on a restricted stock unit vesting, a common administrative tax-withholding mechanism for equity compensation.

How are the indirectly owned Inspire Medical Systems (INSP) shares held for Richard Buchholz?

Richard Buchholz’s indirect ownership in Inspire Medical Systems consists of 1,475 common shares held by his son. These shares are reported as indirect ownership, indicating they are not directly in his personal account but still associated with him.